logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
V

V.P. Stus

ankara university
H指数:19
被引数:6,825

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pembrolizumab plus lenvatinib for previously untreated advanced non-clear cell renal cell carcinoma: 3-year follow-up of the phase 2 KEYNOTE-B61 study

帕博利珠单抗联合仑伐替尼用于初治的透明细胞肾细胞癌以外的晚期肾细胞癌：KEYNOTE-B61研究的3年随访结果

ONCOLOGIST
IF4.2
2025-10-012
OAAI
Albiges, Laurence; Gurney, Howard; Lee, Jae Lyun; Atduev, Vagif; Suarez, Cristina; Climent, Miguel A.; Pook, David; Tomczak, Piotr; Barthelemy, Philippe; Gedye, Craig; Lacombe, Louis; Ferguson, Thomas; Stus, Viktor; Wiechno, Pawel; Erman, Mustafa; Urun, Yuksel; Cornell, Jerry; Burgents, Joe; Sharma, Manish; Voss, Martin
Pembrolizumab plus axitinib versus sunitinib for advanced clear cell renal cell carcinoma: 5-year survival and biomarker analyses of the phase 3 KEYNOTE-426 trial

帕博利珠单抗联合阿昔替尼对比舒尼替尼治疗晚期透明细胞肾细胞癌：KEYNOTE-426 III期试验的5年生存率和生物标志物分析

Nature Medicine
IF50
2025-08-010
OA
Brian I. Rini; Elizabeth R. Plimack; Viktor Stus; Rustem Gafanov; Tom Waddell; Dmitry Nosov; Frédéric Pouliot; Boris Alekseev; Denis Soulières; Bohuslav Melichar; Ihor Vynnychenko; Sergio Jobim de Azevedo; Delphine Borchiellini; Raymond S. McDermott; Jens Bedke; Satoshi Tamada; Sterling Wu; Julia Markensohn; Yiwei Zhang; Andrey Loboda; Amir Vajdi; Rodolfo F. Perini; Joseph Burgents; Thomas Powles
First-line Pembrolizumab Plus Lenvatinib for Advanced Non–clear-cell Renal Cell Carcinoma: Updated Results from the Phase 2 KEYNOTE-B61 Trial

一线帕博利珠单抗联合伦伐替尼治疗晚期非透明细胞肾细胞癌：KEYNOTE-B61 II期试验的更新结果

European Urology
IF25.2
2025-07-240
PRE
Martin H. Voss; Howard Gurney; Vagif Atduev; Cristina Suarez; Miguel A. Climent; David Pook; Piotr Tomczak; Philippe Barthélémy; Jae Lyun Lee; Taron Nalbandian; Viktor Stus; Thomas Ferguson; Pawel Wiechno; Erhan Gokmen; Louis Lacombe; Craig Gedye; Jerry Cornell; Manish Sharma; Joseph E. Burgents; Laurence Albiges
Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study[Eur Urol 84(5) (2023) 449-454]
EUROPEAN UROLOGY
IF25.2
2023-12-010
OA
Plimack, Elizabeth R.; Powles, Thomas; Stus, Viktor; Gafanov, Rustem; Nosov, Dmitry; Waddell, Tom; Alekseev, Boris; Pouliot, Frederic; Melichar, Bohuslav; Soulieres, Denis; Borchiellini, Delphine; McDermott, Raymond S.; Vynnychenko, Ihor; Chang, Yen-Hwa; Tamada, Satoshi; Atkins, Michael B.; Molife, L. Rhoda; Li, Chenxiang; Perini, Rodolfo; Bedke, Jens; Rini, Brian I.
Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study ( vol 84 , pg , 449 , 2023)
EUROPEAN UROLOGY
IF25.2
2023-11-010
OA
Plimack, Elizabeth R.; Powles, Thomas; Stus, Viktor; Gafanov, Rustem; Nosov, Dmitry; Waddell, Tom; Alekseev, Boris; Poulioti, Frederic; Melichar, Bohuslav; Soulieres, Denis; Borchiellini, Delphine; McDermott, Raymond S.; Vynnychenko, Ihor; Chang, Yen-Hwa; Tamada, Satoshi; Atkins, Michael B.; Li, Chenxiang; Perini, Rodolfo; Molife, L. Rhoda; Bedke, Jens; Riniu, Brian I.
Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study
EUROPEAN UROLOGY
IF25.2
2023-11-0130
PRE
Plimack, Elizabeth R.; Powles, Thomas; Stus, Viktor; Gafanov, Rustem; Nosov, Dmitry; Waddell, Tom; Alekseev, Boris; Pouliot, Frederic; Melichar, Bohuslav; Soulieres, Denis; Borchiellini, Delphine; Mcdermott, Raymond S.; Vynnychenko, Ihor; Chang, Yen-Hwa; Tamada, Satoshi; Atkins, Michael B.; Li, Chenxiang; Perini, Rodolfo; Molife, L. Rhoda; Bedke, Jens; Rini, Brian I.
Health-related Quality of Life Analysis from KEYNOTE-426: Pembrolizumab plus Axitinib Versus Sunitinib for Advanced Renal Cell Carcinoma
EUROPEAN UROLOGY
IF25.2
2022-10-0120
PRE
Bedke, Jens; Rini, Brian, I; Plimack, Elizabeth R.; Stus, Viktor; Gafanov, Rustem; Waddell, Tom; Nosov, Dimitry; Pouliot, Frederic; Soulieres, Denis; Melichar, Bohuslav; Vynnychenko, Ihor; Azevedo, Sergio J.; Borchiellini, Delphine; McDermott, Raymond S.; Tamada, Satoshi; Nguyen, Allison Martin; Wan, Shuyan; Perini, Rodolfo F.; Molife, L. Rhoda; Atkins, Michael B.; Powles, Thomas
RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections
CLINICAL INFECTIOUS DISEASES
IF7.3
2019-08-10290
OAAI
Motsch, Johann; de Oliveira, Claudia Murta; Stus, Viktor; Koksal, Iftihar; Lyulko, Olexiy; Boucher, Helen W.; Kaye, Keith S.; File, Thomas M., Jr.; Brown, Michelle L.; Khan, Ireen; Du, Jiejun; Joeng, Hee-Koung; Tipping, Robert W.; Aggrey, Angela; Young, Katherine; Kartsonis, Nicholas A.; Butterton, Joan R.; Paschke, Amanda
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

帕博利珠单抗联合阿西替尼与舒尼替尼治疗晚期肾细胞癌的比较

NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2019-03-212.4K
OAAI
Rini, Brian I.; Plimack, Elizabeth R.; Stus, Viktor; Gafanov, Rustem; Hawkins, Robert; Nosov, Dmitry; Pouliot, Frederic; Alekseev, Boris; Soulieres, Denis; Melichar, Bohuslav; Vynnychenko, Ihor; Kryzhanivska, Anna; Bondarenko, Igor; Azevedo, Sergio J.; Borchiellini, Delphine; Szczylik, Cezary; Markus, Maurice; McDermott, Raymond S.; Bedke, Jens; Tartas, Sophie; Chang, Yen-Hwa; Tamada, Satoshi; Shou, Qiong; Perini, Rodolfo F.; Chen, Mei; Atkins, Michael B.; Powles, Thomas
Fosfomycin for Injection (ZTI-01) Versus Piperacillin-tazobactam for the Treatment of Complicated Urinary Tract Infection Including Acute Pyelonephritis: ZEUS, A Phase 2/3 Randomized Trial

注射用磷霉素 (ZTI-01) 与哌拉西林-他唑巴坦治疗包括急性肾盂肾炎在内的复杂尿路感染: ZEUS，2/3期随机试验

CLINICAL INFECTIOUS DISEASES
IF7.3
2019-03-06108
OAAI
Kaye, Keith S.; Rice, Louis B.; Dane, Aaron L.; Stus, Viktor; Sagan, Olexiy; Fedosiuk, Elena; Das, Anita F.; Skarinsky, David; Eckburg, Paul B.; Ellis-Grosse, Evelyn J.
Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection The TANGO I Randomized Clinical Trial
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
IF55
2018-02-27250
OAAI
Kaye, Keith S.; Bhowmick, Tanaya; Metallidis, Symeon; Bleasdale, Susan C.; Sagan, Olexiy S.; Stus, Viktor; Vazquez, Jose; Zaitsev, Valerii; Bidair, Mohamed; Chorvat, Erik; Dragoescu, Petru Octavian; Fedosiuk, Elena; Horcajada, Juan P.; Murta, Claudia; Sarychev, Yaroslav; Stoev, Ventsislav; Morgan, Elizabeth; Fusaro, Karen; Griffith, David; Lomovskaya, Olga; Alexander, Elizabeth L.; Loutit, Jeffery; Dudley, Michael N.; Giamarellos-Bourboulis, Evangelos J.

研究方向

暂未获取到该数据
B
Brian I. Rini
H 指数:122论文数:1,339被引数:7.7万
E
Elizabeth R. Plimack
H 指数:79论文数:766被引数:4.8万
I
Ihor Vynnychenko
H 指数:32论文数:97被引数:2.1万
R
Rustem Gafanov
H 指数:24论文数:97被引数:7,146
J
Jens Bedke
H 指数:56论文数:606被引数:2.7万
S
Satoshi Tamada
H 指数:26论文数:125被引数:6,738
B
Bohuslav Melichar
H 指数:73论文数:796被引数:4.4万
D
Denis Soulières
H 指数:51论文数:378被引数:2.4万
F
Frédéric Pouliot
H 指数:39论文数:389被引数:1.0万
D
Delphine Borchiellini
H 指数:34论文数:170被引数:7,816